Derek Hicks's most recent trade in Intellia Therapeutics Inc was a trade of 6,502 Common Stock done at an average price of $12.2 . Disclosure was reported to the exchange on Jan. 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Intellia Therapeutics Inc | Derek Hicks | EVP, Chief Business Officer | Sale of securities on an exchange or to another person at price $ 12.18 per share. | 03 Jan 2025 | 6,502 | 59,878 (0%) | 0% | 12.2 | 79,194 | Common Stock |
| Intellia Therapeutics Inc | Derek Hicks | EVP, Chief Business Officer | 01 Mar 2024 | 42,421 | 42,421 | - | - | Stock Option (right to buy) | ||
| Intellia Therapeutics Inc | Derek Hicks | EVP, Chief Business Officer | 01 Mar 2024 | 29,393 | 66,380 (0%) | 0% | 0 | Common Stock | ||
| Intellia Therapeutics Inc | Derek Hicks | EVP, Chief Business Officer | 03 Jan 2024 | 3,877 | 36,987 (0%) | 0% | 29.5 | 114,216 | Common Stock | |
| Intellia Therapeutics Inc | Derek Hicks | EVP, Chief Business Officer | 01 Mar 2023 | 33,287 | 33,287 | - | - | Stock option (right to buy) | ||
| Intellia Therapeutics Inc | Derek Hicks | EVP, Chief Business Officer | 01 Mar 2023 | 23,558 | 40,864 (0%) | 0% | 0 | Common Stock | ||
| Intellia Therapeutics Inc | Derek Hicks | EVP, Chief Business Officer | 04 Jan 2023 | 1,812 | 17,306 (0%) | 0% | 37.2 | 67,425 | Common Stock | |
| Intellia Therapeutics Inc | Derek Hicks | EVP, Chief Business Officer | 03 Jan 2022 | 25,000 | 25,000 | - | - | Stock option (right to buy) | ||
| Intellia Therapeutics Inc | Derek Hicks | EVP, Chief Business Officer | 03 Jan 2022 | 19,118 | 19,118 (0%) | 0% | 0 | Common Stock |